GLP-1 receptor agonists like semaglutide and tirzepatide have transformed weight loss and diabetes management by regulating blood sugar, promoting satiety, and supporting long-term metabolic health. However, standard dosing isn’t ideal for everyone, leading to growing interest in microdosing—using lower-than-standard doses for improved tolerance and sustained benefits.

What Is Microdosing GLP-1s?

Microdosing involves taking around 25% of the usual starting dose to:

• Reduce long-term health risks – Supports heart health, neuroprotection, and inflammation reduction in conditions like Polycystic Ovary Syndrome (PCOS) and autoimmune disorders.
• Minimize side effects – Helps prevent nausea, vomiting, and stomach discomfort while allowing the body to adjust smoothly.
• Sustain weight loss – Maintains benefits without requiring high-dose escalation.
• Support long-term metabolic health – Enhances insulin sensitivity, appetite regulation, and overall wellness even at lower doses.

Top Benefits of Microdosing GLP-1s

• Fewer Side Effects, Better Tolerance – A gentler approach that makes treatment more manageable.
• Metabolic Benefits Without Excessive Weight Loss – Ideal for those seeking health improvements beyond weight reduction.
• Cost-Effective, Long-Term Maintenance – Supports sustained weight loss and metabolic stability while lowering medication costs.

How to Implement Microdosing

If you’re interested in microdosing, consult with your healthcare provider to determine the best approach. Options may include lower doses or extended injection intervals (e.g., every 10–14 days instead of weekly) to balance effectiveness with minimal side effects.

For more information on whether GLP-1 microdosing is right for you, contact Flow Wellness for a no-fee consultation to discuss a personalized treatment plan. We treat patients in California, Oregon, & Washington.